BIOMAT Database Logo BIOMAT Database Logo

Discovery of 4H-pyrazolo[1,5-a]pyrimidin-7-ones as potent inhibitors of hepatitis C virus polymerase. 2009

Yongqi Deng, and Gerald W Shipps, and Tong Wang, and Janeta Popovici-Muller, and Kristin E Rosner, and M Arshad Siddiqui, and Jose Duca, and Alan B Cooper, and Michael Cable
Schering-Plough Research Institute Cambridge, 320 Bent Street, Cambridge, MA 02141, United States. yongqi.deng@spcorp.com

A series of 4H-pyrazolo[1,5-a]pyrimidin-7-one derivatives was synthesized and evaluated for inhibitory activity against HCV NS5B RNA-dependent RNA polymerase. A number of these compounds exhibited potent activity in enzymatic assay. The synthesis and structure-activity relationship are also described.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D012324 RNA-Dependent RNA Polymerase An enzyme that catalyses RNA-template-directed extension of the 3'- end of an RNA strand by one nucleotide at a time, and can initiate a chain de novo. (Enzyme Nomenclature, 1992, p293) Nucleoside-Triphosphate:RNA Nucleotidyltransferase (RNA-directed),RNA Replicase,RNA-Dependent RNA Replicase,RNA-Directed RNA Polymerase,RNA Dependent RNA Polymerase,RNA Dependent RNA Replicase,RNA Directed RNA Polymerase,RNA Polymerase, RNA-Dependent,RNA Polymerase, RNA-Directed,RNA Replicase, RNA-Dependent,Replicase, RNA,Replicase, RNA-Dependent RNA
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D016174 Hepacivirus A genus of FLAVIVIRIDAE causing parenterally-transmitted HEPATITIS C which is associated with transfusions and drug abuse. Hepatitis C virus is the type species. Hepatitis C virus,Hepatitis C-Like Viruses,Hepaciviruses,Hepatitis C Like Viruses,Hepatitis C viruses,Hepatitis C-Like Virus
D017361 Viral Nonstructural Proteins Proteins encoded by a VIRAL GENOME that are not structural components of VIRUS PARTICLES. Some of these proteins may play roles within the infected cell during VIRUS REPLICATION or act in regulation of virus replication or VIRUS ASSEMBLY. Nonstructural Proteins, Viral,NS Proteins, Viral,Viral NS Proteins,Viral Non-Structural Proteins,Viral Nonstructural Protein,Viral Nonstructural Proteins NS1,Viral Nonstructural Proteins NS2,Nonstructural Protein, Viral,Viral Non Structural Proteins

Related Publications

Yongqi Deng, and Gerald W Shipps, and Tong Wang, and Janeta Popovici-Muller, and Kristin E Rosner, and M Arshad Siddiqui, and Jose Duca, and Alan B Cooper, and Michael Cable
Structure-Activity Relationships of Pyrazolo[1,5-a]pyrimidin-7(4H)-ones as Antitubercular Agents.
February 2021, ACS infectious diseases,
Yongqi Deng, and Gerald W Shipps, and Tong Wang, and Janeta Popovici-Muller, and Kristin E Rosner, and M Arshad Siddiqui, and Jose Duca, and Alan B Cooper, and Michael Cable
6-Nitroazolo[1,5-a]pyrimidin-7(4H)-ones as Antidiabetic Agents.
December 2017, Archiv der Pharmazie,
Yongqi Deng, and Gerald W Shipps, and Tong Wang, and Janeta Popovici-Muller, and Kristin E Rosner, and M Arshad Siddiqui, and Jose Duca, and Alan B Cooper, and Michael Cable
Optimisation of pyrazolo[1,5-a]pyrimidin-7(4H)-one derivatives as novel Hsp90 C-terminal domain inhibitors against Ewing sarcoma.
February 2023, Bioorganic chemistry,
Yongqi Deng, and Gerald W Shipps, and Tong Wang, and Janeta Popovici-Muller, and Kristin E Rosner, and M Arshad Siddiqui, and Jose Duca, and Alan B Cooper, and Michael Cable
Design, synthesis and biological activity of pyrazolo[1,5-a]pyrimidin-7(4H)-ones as novel Kv7/KCNQ potassium channel activators.
March 2011, European journal of medicinal chemistry,
Yongqi Deng, and Gerald W Shipps, and Tong Wang, and Janeta Popovici-Muller, and Kristin E Rosner, and M Arshad Siddiqui, and Jose Duca, and Alan B Cooper, and Michael Cable
Surrogating and redirection of pyrazolo[1,5-a]pyrimidin-7(4H)-one core, a novel class of potent and selective DPP-4 inhibitors.
February 2018, Bioorganic & medicinal chemistry,
Yongqi Deng, and Gerald W Shipps, and Tong Wang, and Janeta Popovici-Muller, and Kristin E Rosner, and M Arshad Siddiqui, and Jose Duca, and Alan B Cooper, and Michael Cable
Synthesis and pharmacological evaluation of pyrazolo[1,5-a]pyrimidin-7(4H)-one derivatives as potential GABAA-R ligands.
March 2017, Bioorganic & medicinal chemistry,
Yongqi Deng, and Gerald W Shipps, and Tong Wang, and Janeta Popovici-Muller, and Kristin E Rosner, and M Arshad Siddiqui, and Jose Duca, and Alan B Cooper, and Michael Cable
Identification of substituted pyrazolo[1,5-a]quinazolin-5(4H)-one as potent poly(ADP-ribose)polymerase-1 (PARP-1) inhibitors.
August 2009, Bioorganic & medicinal chemistry letters,
Yongqi Deng, and Gerald W Shipps, and Tong Wang, and Janeta Popovici-Muller, and Kristin E Rosner, and M Arshad Siddiqui, and Jose Duca, and Alan B Cooper, and Michael Cable
Discovery of pentacyclic compounds as potent inhibitors of hepatitis C virus NS5B RNA polymerase.
February 2009, Bioorganic & medicinal chemistry letters,
Yongqi Deng, and Gerald W Shipps, and Tong Wang, and Janeta Popovici-Muller, and Kristin E Rosner, and M Arshad Siddiqui, and Jose Duca, and Alan B Cooper, and Michael Cable
Activation of KCNQ2/3 potassium channels by novel pyrazolo[1,5-a]pyrimidin-7(4H)-one derivatives.
January 2011, Pharmacology,
Yongqi Deng, and Gerald W Shipps, and Tong Wang, and Janeta Popovici-Muller, and Kristin E Rosner, and M Arshad Siddiqui, and Jose Duca, and Alan B Cooper, and Michael Cable
Discovery and characterization of a novel 7-aminopyrazolo[1,5-a]pyrimidine analog as a potent hepatitis C virus inhibitor.
December 2012, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!